A blueprint for advancing genetics-based cancer therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21962504.
- Also identified by DOI 10.1016/j.cell.2011.09.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic contributions to the therapy of disease more broadly.
Medical subject headings
- Genome, Human
- Neoplasms